Articles about 'Christopher Dobson'

Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases.

Researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease. 

The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, was officially opened today in Cambridge. 

Leaders in fields from classics to Alzheimer’s research are recognised today in the Queen's Birthday Honours list.

Researchers have shown how cholesterol – a molecule normally linked with cardiovascular diseases – may also play an important role in the onset and progression of Alzheimer’s disease. 

Gifts totalling more than £32 million, together with government funds of over £17 million, have enabled the launch of a highly innovative Centre in Cambridge that is pioneering new approaches to understand and treat neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, motor neurone disease and frontotemporal dementia.

New funding will support fundamental research into the molecular processes underlying human disorders such as Alzheimer’s and Parkinson’s diseases, and enable new ways to combat them.

Professor Christopher Dobson, Master of St John’s, and Professor Jorge Guimarães, President of CAPES, sign agreement for the creation of the Celso Furtado Visiting Fellowship in Brazilian History and Humanities

New research establishes nature of malfunction in protein molecules that can lead to onset of dementia.